Postprandial Distress Syndrome
9
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
44%
4 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
Acotiamide vs Itopride in Postprandial Distress Syndrome
Postprandial Distress Itopride Cohort Trial
Primary Care dySpEpsia rikkuNshiTo
International Clinical Study of Zhizhu Kuanzhong Capsule
Efficacy of a Modified Banxia Xiexin Decoction for the "Wei-Pi" Syndrome (Postprandial Distress Syndrome)
Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS)
Acupuncture for Patients With Function Dyspepsia